PADLOCK THERAPEUTICS

Padlock is developing medicines targeting protein-arginine deiminases (PADs), enzymes with an important role in the generation of autoantigens, inflammation, and immune complexes in autoimmune diseases. Padlock intends to explore the full biological and therapeutic footprint of protein deimination by PADs. Padlock was founded by scientists at The Scripps Research Institute and members of the Atlas Venture Life Sciences Team. Padlock's investors include Atlas Venture, Johnson & Johnson, and MS Ventures. Padlock is a seed company operating out of the Atlas Venture office in Cambridge MA.

#SimilarOrganizations #People #Financial #Website #More

PADLOCK THERAPEUTICS

Social Links:

Twitter

Industry:

Biotechnology Health Care Life Science Therapeutics

Founded:

2014-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.padlocktherapeutics.com

Total Employee:

10001+

Status:

Active

Contact:

(978) 381-9601

Email Addresses:

[email protected]

Total Funding:

37.68 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Content Delivery Network Google Universal Analytics New Relic Google Analytics IP Anonymization Add To Any Snowplow